Related Experiment Video
Updated: Sep 1, 2025

09:37
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Published on: March 5, 2017
13.2K
Correction of Fanconi Anemia Mutations Using Digital Genome Engineering
Christopher J Sipe1,2,3,4, Mitchell G Kluesner1,2,3,4,5, Samuel P Bingea1,2,3,4
1Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
International Journal of Molecular Sciences
|August 12, 2022
Summary
Digital genome editing using base editors (BEs) corrects Fanconi anemia (FA) mutations without inducing DNA breaks. This approach rescues FA cells and enables potential autologous stem cell transplants for treating this genetic disease.
Area of Science:
- Genetics and Genomics
- Hematology
- Gene Therapy
Background:
- Fanconi anemia (FA) is a rare genetic disorder characterized by DNA repair pathway defects, leading to bone marrow failure and cancer.
- Allogeneic hematopoietic cell transplant (HCT) is curative but limited by donor availability and risks like graft-versus-host disease (GvHD).
- Current gene-editing strategies for autologous HCT are inefficient in FA cells due to inherent DNA repair deficiencies.
Purpose of the Study:
- To investigate the efficacy of base editors (BEs) for correcting Fanconi anemia mutations in patient-derived cells.
- To establish a gene-editing approach that circumvents the need for DNA double-strand breaks (DSBs) and donor DNA.
- To demonstrate the potential of this 'digital' genome editing for autologous stem cell therapy in FA.
Main Methods:
- Utilized cytosine and adenine base editors (BEs) for precise C:G > T:A and A:T > C:G base transitions in FANCA genes.
- Applied digital genome editing to primary Fanconi anemia patient cells, avoiding DSB induction and homology-directed repair (HDR).
- Assessed phenotypic rescue by measuring resistance to Mitomycin C (MMC) and restored FANCA protein expression and FA pathway function.
Main Results:
- Successfully corrected FANCA mutations in primary FA patient cells using base editors.
- Demonstrated phenotypic rescue, including resistance to Mitomycin C (MMC), and restored FANCA protein expression.
- Confirmed functional FA pathway restoration through FANCD2 monoubiquitination induction.
Conclusions:
- Base editor-mediated digital genome editing offers an efficient strategy for correcting FA mutations without inducing DSBs.
- This approach enables the potential use of gene-corrected autologous hematopoietic stem and progenitor cells (HSPCs) for FA treatment.
- Digital genome editing provides a promising alternative to allogeneic HCT, mitigating risks associated with donor limitations and DSB induction.
Keywords:
CRISPR-Cas9Fanconi anemia (FA)Fanconi anemia repair pathwayadenine base editing (ABE)base editingbase excision repairbone marrow failurecytosine base editing (CBE)digital genome engineeringdouble strand breaksgene therapy
